Diluted cancer medication scandal widens in Germany
August 17, 2017
German activists have demanded tougher controls after thousands of patients reportedly received diluted cancer medications. Reports suggest the scandal can be traced to a single pharmacist acting out of financial gain.
The pharmacist, identified as Peter S., is also under suspicion for overcharging on some 50,000 prescriptions. The financial damage to health insurance companies is estimated at around 56 million euros ($65.7 million). German authorities arrested the man in late 2016.
According to recent media reports, the man had been tampering with cancer medications for years while working in a large pharmacy in the western German town of Bottrop. The pharmacy allegedly delivered the diluted drugs to several German states and dozens of clinics and private practices. Some 3,700 patients are believed to have been affected since January 2012.
The activist Brysch greeted the move, saying it was "overdue," and urged other German states to follow suit. The Bottrop scandal allegedly affected patients in six German states.
How exercise is helping cancer patients
According to public broadcaster WDR, the scheme was discovered by the pharmacy's commercial manager, who compared the amount of medication the pharmacy had purchased with the amount it was selling. The move showed that some medication sold only had one-fifth of the active ingredients they were meant to contain.
German courts have not yet launched a trial against the pharmacist. The authorities have yet to inform all the affected patients, and are working on gathering their contact information, according to Laumann.